Background: Non-communicable diseases (NCD) are a health burden impacting quality of life. Objective: To observe the effect of homoeopathic treatment in NCDs on clinical and laboratory parameters and to evaluate changes in patient’s own assessment of their complaints. Methodology: An open-label, prospective, OPD-based observational study was conducted from May 2019 to March 2021 at ten centres across India. Individualised treatment was given with six months follow-up, and relevant clinical and laboratory investigations were performed. Measure Yourself Medical Outcome Profile2 (MYMOP2) and Simple Lifestyle Indicator Questionnaire (SLIQ) are the study instruments used. Results: 905 NCD patients enrolled. The mean age ±SD of the study participants is 50.32 years (±13.40). The most common NCDs are diabetes mellitus (N= 306), hypertension (197), and multimorbidity (166), with a mean (SD) duration of suffering of 4.80 (±6.06) years. A significant change (p<0.001) in all the subscales and profile scores of the MYMOP2 scale was reported after treatment. The systolic and diastolic blood pressure decreased significantly (p<0.0001). Many laboratory parameters also significantly decreased, such as triglycerides (166.5 to 131.6 mg/dl, p< 0.0001) and low-density lipoprotein (113.6 to 101.3 mg/dl, p= 0.0019). The pair-wise comparison of the SLIQ category score at two-time points showed a statistically significant effect (p=0.030) of homoeopathic treatment on the patient's lifestyles. Conclusion: The study demonstrated a beneficial effect of homeopathic treatment, supporting its potential integration with standard care in managing NCDs. There is a need for homeopathic clinical registries to generate larger datasets and assess long-term clinical outcomes.
Varanasi et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: